Alpha Tau Medical DRTS
NASDAQ DRTS
$15.03 +0.41 (+2.80%)
As of: Sep 4, 2026 · 3:59 PM EDT

Alpha Tau Medical (DRTS) Long-Term Deferred Tax (2020 - 2025)

Alpha Tau Medical (DRTS) posted Long-Term Deferred Tax of $97000.0 for Q4 2025, down 97.45% sequentially from $3.8 million in Q4 2021.

Analysis

Alpha Tau Medical (DRTS) Long-Term Deferred Tax (2020 - 2025) Analysis & Trends

Alpha Tau Medical has reported Long-Term Deferred Tax for 3 years, with the latest figure at $97000.0 in Q4 2025.

  • Quarterly Long-Term Deferred Tax changed N/A year-over-year to $97000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $97000.0 (changed N/A YoY) and the FY2025 annual result came in at $97000.0, changed N/A from the prior year.
  • Long-Term Deferred Tax slipped to $97000.0 in Q4 2025 per DRTS's latest filing, from $3.8 million in the prior quarter.
  • Over five years, Long-Term Deferred Tax peaked at $3.8 million in Q4 2021 and troughed at $97000.0 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Alpha Tau Medical 1.21 Bn 1.11 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 97,000.00
Dec 31, 2021 3.80 Mn
Dec 31, 2020 2.23 Mn